Immunological Aspects in Late Phase of Living Donor Liver Transplant Patients: Usefulness of Monitoring Peripheral Blood CD4+ Adenosine Triphosphate Activity

Table 3

Relationship between the patients with infectious complication or acute rejection and those divided by CYP3A5 genotype.

	EX-R/EX-D; (𝑛=5)	EX-R/NEX-D; (𝑛=6)	NEX-R/EX-D; (𝑛=10)	NEX-R/NEX-D; (𝑛=18)	Value
Infection	0	1 (16.7%)	3 (30%)	5 (27.7%)	n.s.
Rejection	1 (25%)	1 (16.7%)	1 (10%)	1 (5.5%)	n.s.

EX: expressor (*1/*1 or *1/*3), NEX: nonexpressor (*3/*3).
EX-R: recipient with EX, NEX-R: recipient with NEX.
EX-D: donor with EX, NEX-D: donor with NEX.
n.s.: nonsignificant.